Cargando…

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?

Detalles Bibliográficos
Autor principal:	Hennenfent, B
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 1997
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627597/ https://www.ncbi.nlm.nih.gov/pubmed/9126451

Ejemplares similares

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Benign Prostatic Hyperplasia
Publicado: (2015)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
por: Cohen, P., et al.
Publicado: (1998)

The authors reply: Korean clinical practice guideline for benign prostatic hyperplasia
por: Yeo, Jeong Kyun, et al.
Publicado: (2016)

Letter to the editor: Korean clinical practice guideline for benign prostatic hyperplasia
por: Jung, Jae Hung, et al.
Publicado: (2016)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Prostate Stem Cells in the Development of Benign Prostate Hyperplasia and Prostate Cancer: Emerging Role and Concepts
por: Prajapati, Akhilesh, et al.
Publicado: (2013)

Is Serenoa repens Effective in the Treatment of Benign Prostatic Hyperplasia?
por: Çeker, Gökhan
Publicado: (2020)

Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer
por: Zhang, Li, et al.
Publicado: (2016)

Postoperative Infectious Complications in Our Early Experience With Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
por: Shigemura, Katsumi, et al.
Publicado: (2013)

The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia
por: Liu, Jiang, et al.
Publicado: (2023)

Effect of Nocturia on Quality of Life among Clients with Benign Prostatic Hyperplasia
por: Varughese, Susamma, et al.
Publicado: (2021)

Commentary on “Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea”
por: Shin, Yu Seob, et al.
Publicado: (2021)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Letter to the editor: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
por: Kadihasanoglu, Mustafa, et al.
Publicado: (2015)

The authors reply: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
por: Kabir, Ali, et al.
Publicado: (2015)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Rare Variant of Carcinoma Prostate Masquerading as Benign Prostatic Hyperplasia
por: Khanduri, Sachin, et al.
Publicado: (2019)

Prostate sarcomas: A radiological mimic for benign prostatic hyperplasia
por: Whish-Wilson, Thomas, et al.
Publicado: (2020)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
por: Ratajczak, Weronika, et al.
Publicado: (2022)

Value for Money in Disease Management of Benign Prostatic Hyperplasia
por: Curtiss, Frederic R.
Publicado: (2004)

The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer
por: Oseni, Saheed Oluwasina, et al.
Publicado: (2023)

Minimally invasive simple prostatectomy for a case of giant benign prostatic hyperplasia
por: Zeng, Qin-Song, et al.
Publicado: (2017)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_bt9r5sru58nu1g34ahi24momqu